Explore immunotherapy discoveries, treatment approvals and milestones.
See Our Breakthroughs
Working to make a difference in the lives of all affected by cancer.
Learn About Our Work
Find clinical trials that match your diagnosis, stage and treatment history.
Search Online
Learn more about this revolutionary cancer treatment.
Understand the Basics
Meet the CRI scientists committed to the development of immunotherapy.
Read More
The Cancer Research Institute announced today that it will honor biotechnology company Genentech and real estate developer and philanthropist Bruce Ratner with the 2017 Oliver R. Grace Award for Distinguished Service in Advancing Cancer Research.
Drs. Rafi Ahmed and Thomas F. Gajewski will receive the 2017 William B. Coley Award, and Dr. Shannon Turley will receive the 2017 Frederick W. Alt Award.
Cancer Research Institute collaboration with the Parker Institute for Cancer Immunotherapy, Bristol-Myers Squibb, and Apexigen will test CD40 antibody APX005M, nivolumab, and chemotherapy in pancreatic cancer patients.
First-of-its kind campaign to fund promising immunotherapy research in Israel, a global leader in cancer research
Fight Colorectal Cancer and the Cancer Research Institute announce the recipient of their jointly-funded $400k grant to support immunotherapy research in metastatic colorectal cancer.
Cancer Research Institute | National Headquarters 29 Broadway, 4th Floor | New York, NY 10006-3111
(800) 992-2623(212) 832-9376Staff Directory
FDA approves new immunotherapy--Yescarta (axicabtagene ciloleucel)--for adult patients with relapsed or refractory non-Hodgkin large B cell lymphoma.
CRI among 12 top-rated cancer charities within a subset of organizations doing good work in breast cancer as well as other forms of cancer.